Optimi Health Corp. 提交 6-K 外国私人发行人报告
6-K - Optimi Health Corp. (0002027329) (Filer)
Optimi Health Corp. 向美国证券交易委员会提交了 6-K 外国私人发行人报告，报告月份为 2026 年 10 月。文件列出一份 99.1 号新闻稿作为附件，并由公司首席执行官、首席营销官兼董事 Dane Stevens 于 10 月 26 日签署。
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number: 001-43304
Optimi Health Corp.
(Translation of registrant's name into English)
269 David Brown Way
Princeton, B.C. V0X 1W0
Canada
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
EXHIBIT INDEX
| Exhibit | Description of Exhibit | |
| 99.1 | Press Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Optimi Health Corp. | ||
| (Registrant) | ||
| Date: October 26, 2026 | /s/ Dane Stevens | |
| Dane Stevens | ||
| Chief Executive Officer, Chief Marketing Officer and Director | ||
来源：SEC EDGAR · 本站存档